CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 22 No. 5
Announcements 

New Screening Test Could Reduce Oral Cancer Fatalities

April 30, 2008

A tiny lightstick called ViziLite Plus could help prevent 90% of all fatalities from oral cancer, according to the California-based Creative Dimensions in Dentistry (www.cddentists.com), a dental group that recommends all adults ask their dentists for the procedure.

"I predict that this screening procedure with this product will become as widespread as the PAP smear or PSA test," said Dr. Michael Erickson, a dentist at Creative Dimensions in Dentistry of San Leandro and Castro Valley, Calif. Erickson believes that the oral screening procedure with this new product will be as common as the tests for cervical and prostate cancer that are now routine elements of patients' regular diagnostic screening.

Quick, Painless Procedure

"Oral cancer is on the rise, with one American dying every hour from the disease, but early treatment is 90% effective," said Erickson. "The ViziLite Plus, used along with head and neck exams, can help dentists detect oral cancer early."

The procedure is painless and usually takes about 5 minutes. ViziLite is a small disposable, fluorescent light stick about the size of a thermometer. After the patient rinses for about 2 minutes with a raspberry-flavored solution, the doctor shines the ViziLite inside the patient's mouth to examine the mouth, lips, and inner cheeks.Cancerous tissue looks white under ViziLite, while normal tissue looks dark.

Health insurance plans do not yet cover the test, which costs about $65.00, according to Erickson.

Though smokers and tobacco users are particularly vulnerable to oral cancer and would especially benefit from ViziLite, 27% of people with oral cancer do not use tobacco or have other lifestyle risk factors, according to Erickson. "This underscores the importance of early screening."

'Small Price to Pay'

"The lack of early detection is the reason the incidence of oral cancer has increased by 5.5% and the death rate has increased by 1.5%, according to the American Cancer Society," noted Erickson.

"We believe the cost of the procedure is a small price to pay to detect oral cancer before it's too late, or for the peace of mind when you discover there's no problem and you get a clean bill of oral health," said Erickson.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Tammy Nance | June 11, 2010 10:15 PM EDT

I was 39 years old this past November with no risk factors and no family history of cancer, when I was diagosed with tongue cancer.  I wish I had been able to have taken this test at my dentist before the cancer spread to my lymph nodes.  I am happy to report I have been in remission since then and I found a wonderful Doctor at the Mayo Clinic who diagnosed me and did my surgery! Thank you Dr Kerry Olsen!






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy